These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 1398633)

  • 41. Accidental coadministration of intravenous aminophylline and theophylline by mouth: a hazardous practice.
    Frewin DB; Cooper DJ
    Med J Aust; 1986 Apr; 144(9):481-2. PubMed ID: 3702795
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Bioavailability of theophylline from a sustained-release aminophylline formulation (Euphyllin retard tablets)--plasma levels after single and multiple oral doses.
    Schuppan D; Molz KH; Staib AH; Rietbrock N
    Int J Clin Pharmacol Ther Toxicol; 1981 May; 19(5):223-7. PubMed ID: 7251238
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Plasma theophylline concentration and lung function in ponies with recurrent obstructive lung disease.
    McKiernan BC; Koritz GD; Scott JS; Berney C; Robinson NE
    Equine Vet J; 1990 May; 22(3):194-7. PubMed ID: 2361508
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Individually-adjusted dosages of aminophylline in children with bronchial asthma].
    Paditz E; Gramatté T; Leupold W; Richter K; Feller K
    Kinderarztl Prax; 1990 Nov; 58(11):567-74. PubMed ID: 2098615
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Aminophylline loading in asthmatic patients: a protocol trial.
    Stine RJ; Marcus RH; Parvin CA
    Ann Emerg Med; 1989 Jun; 18(6):640-6. PubMed ID: 2658694
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Pharmacokinetic and clinical effectiveness of rectally administered theophylline].
    Bracher P; Brändli O
    Respiration; 1982; 43(6):458-66. PubMed ID: 7178675
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Dose dependency of aminophylline effects on hemodynamic and ventricular function in patients with chronic obstructive pulmonary disease.
    Mols P; Huynh CH; Dechamps P; Naeije N; Ham HR
    Chest; 1993 Jun; 103(6):1725-31. PubMed ID: 8404091
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The hemodynamic effects of aminophylline and salbutamol alone and in combination.
    Burgess CD; Crane J; Graham AN; Maling TJ
    Clin Pharmacol Ther; 1986 Nov; 40(5):550-3. PubMed ID: 3533371
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pharmacokinetics of sustained release and conventional tablets of theophylline plus hydroxyethyltheophylline and its comparison with tablet aminophylline.
    Gupta S; Raina RK; Samotra K; Gupta KL
    Indian J Chest Dis Allied Sci; 1991; 33(1):1-8. PubMed ID: 1791015
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Theophylline pharmacokinetics in patients with mild or severe airway obstruction.
    Rizzo A; Mirabella A; Ferrara G; Pipitone P; Bellia V; Bonsignore G
    Bull Eur Physiopathol Respir; 1982; 18(6):811-8. PubMed ID: 6927536
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Bronchodilators in patients with chronic obstructive pulmonary disease on mechanical ventilation. Utilization of metered-dose inhalers.
    Fernandez A; Lazaro A; Garcia A; Aragon C; Cerda E
    Am Rev Respir Dis; 1990 Jan; 141(1):164-8. PubMed ID: 2136979
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Theophylline blood levels after administration of Euphyllin retard (author's transl)].
    Ahrens J
    Dtsch Med Wochenschr; 1977 Apr; 102(13):482-6. PubMed ID: 844428
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Differences in steady-state plasma levels between aminophylline and theophylline sustained-release micropellets after repeated circadian dosing.
    Schulz HU; Steinijans VW; Gabel H
    Int J Clin Pharmacol Ther Toxicol; 1984 Nov; 22(11):621-5. PubMed ID: 6500759
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Theophylline concentrations in patients with acute exacerbation of COPD.
    Emerman CL; Connors AF; Lukens TW; May ME; Effron D
    Am J Emerg Med; 1990 Jul; 8(4):289-92. PubMed ID: 2363749
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Aminophylline-retard preparation in the treatment of patients with bronchial asthma].
    Branica S; Vrabec B; Francetić I; Bakran I
    Lijec Vjesn; 1989; 111(9-10):341-3. PubMed ID: 2633012
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Aminophylline, respiratory muscle strength and exercise tolerance in chronic obstructive airway disease.
    Cooper CB; Davidson AC; Cameron IR
    Bull Eur Physiopathol Respir; 1987; 23(1):15-22. PubMed ID: 3297214
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A single oral dose method for predicting steady state theophylline concentrations in clinical practice.
    Mann JS; Fitzpatrick RW; Jones PW; Prowse K; Mucklow JC; Cole RB
    Respir Med; 1990 Nov; 84(6):479-84. PubMed ID: 2274687
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Relation of dose, serum concentration and side effects in intravenous aminophylline therapy].
    Katz G; Kewitz G; Vozeh S; Follath F
    Schweiz Med Wochenschr; 1981 Dec; 111(52):2054-6. PubMed ID: 7330656
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Theophylline kinetics in acute pulmonary edema.
    Piafsky KM; Sitar DS; Rangno RE; Ogilvie RI
    Clin Pharmacol Ther; 1977 Mar; 21(3):310-6. PubMed ID: 837650
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Oral sustained-release aminophylline in medical inpatients: factors related to toxicity and plasma theophylline concentrations.
    Ramsay LE; Mackay A; Eppel ML; Oliver JS
    Br J Clin Pharmacol; 1980 Aug; 10(2):101-7. PubMed ID: 7426271
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.